Amitell Capital Pte Ltd / STOK
Amitell Capital Pte Ltd’s Stoke Therapeutics Inc Position
Does Amitell Capital Pte Ltd own Stoke Therapeutics Inc (STOK)? Not currently — the last reported position was 64.8K shares worth $856,000 in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$856,000
Q2 2022
Shares
64.8K
% of Portfolio
+1.95%
Quarters Held
2
position exited
Position History STOK
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amitell Capital Pte Ltd’s full portfolio or all institutional holders of STOK.